Strengthening Muscle-Invasive Bladder Cancer Care: The Untapped Potential of Perioperative Systemic Therapy

Apr 9, 2026 | Blog

Bladder cancer remains a major global health challenge, ranking as the tenth most common cancer overall and the sixth among men. Yet across geographies, the burden of disease looks very different, driven by a complex mix of environmental exposures, diagnostic...

How Taichung Veterans General Hospital is Advancing Real-World Evidence Research with TriNetX

Apr 8, 2026 | Network Spotlight

We’re pleased to recognize Taichung Veterans General Hospital (TCVGH) as our Q2 2026 Network Spotlight winner!   TCVGH has embraced real-world data (RWD) to drive clinical research and deliver evidence-based care. Through their partnership with TriNetX, the...

TriNetX Enhances its Ability to Federate Genomics Data Across its Global Network of Providers through the Acquisition of Key Assets of Zetta Genomics

Apr 7, 2026 | Press Releases

TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient care innovation Cambridge, MA and Cambridge, UK — April 7, 2026 — TriNetX, the world’s leading federated health data...

Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions

Apr 2, 2026 | Press Releases

Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX’s industry-leading global network of electronic health record data Collaboration will expand Regeneron’s world-leading genomic and proteomic EHR-linked database ...

Accelerating Study Design Decisions with Real‑World Data

Apr 1, 2026 | Blog

Designing a clinical study has never been more complex—or more consequential. As protocols grow increasingly restrictive and timelines tighten, early design decisions can determine whether a study launches smoothly or struggles with amendments, delays, and...

Patient-Centricity at the Point of Care: A Clinician’s Perspective on Rethinking Trials

Feb 12, 2026 | Blog

When I think about the phrase “patient-centricity,” I often pause. It’s everywhere in our industry: clinical trial brochures, conference panels, even corporate mission statements. But too often, it risks becoming a buzzword rather than a lived reality.  In our...

TriNetX Named Best of Show Finalist at SCOPE: Advancing Clinical Trial Planning with Conversational AI and Enhanced API Capabilities

Feb 9, 2026 | Blog

TriNetX is proud to announce that we were named a Best of Show Finalist at SCOPE, the summit for clinical ops executives, one of the industry’s premier events focused on advancing clinical operations and innovation. This recognition highlights our continued commitment...

Insights from the Healthcare System for Patient-Centric Trials at the Point of Care

Jan 27, 2026 | Inside the Trends

Patient-centricity is everywhere in clinical research. But what does it actually look like inside real healthcare systems?  In this episode of Inside the Trends, we move beyond theory to explore how clinical trials can truly align with the realities of patient...

Finding the Unfindable: How One Healthcare Organization is Using TriNetX to Identify Underdiagnosed Heart Disease

Jan 23, 2026 | Network Spotlight

We’re proud to announce Worcestershire Acute Hospitals NHS Trust as our Q1 2026 Network Spotlight winner!  Led by Dr. David Wilson, Consultant Cardiologist at Worcestershire Acute Hospitals NHS Trust, a groundbreaking quality improvement project is demonstrating how...

TriNetX Unveils Conversational AI Interface and Enhanced API Capabilities

Jan 22, 2026 | Press Releases

Success achieved in reducing trial costs and timelines drives 2026 platform enhancements designed to democratize clinical research analytics.  CAMBRIDGE, Mass., January 22, 2026 — TriNetX, driven by its vision of a connected world where data and intelligence power...